Skip to content
healthcare.dev
Get a free key

TAVALISSE

NDC 71332-002, FOSTAMATINIB, tablet, from Rigel Pharmaceuticals, Inc..

Product NDC
71332-002
Status
Listed
Labeler
Rigel Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209299
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71332-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSTAMATINIB150 mg/1
Package NDCNDC-11Package
71332-002-017133200020160 TABLET in 1 BOTTLE (71332-002-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21149cc3-049b-43e2-b141-c9499160556c

Use it

Look up 71332-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71332-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71332-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.